Health Condition 1: D509- Iron deficiency anemia, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Hb between 7 to 11.5 mg/dl in female and 7 to 13.5 mg/dl in male. Sr.Ferritin less than 15 ng/ml in female and less than 30 ng/dl in male. Sr.iron less than 50 ug/L TIBC greater than 250 ug/L Pt who withdraw from oral or parental iron therapy.
Exclusion criteria
Exclusion criteria: K/C/O Thalassemia/Aplastic Anaemia/sickle cell Anaemia/Megaloblastic Anaemia. K/C/O any haemorrhagic disorder i.e. active bleeding. K/C/O any systemic disorder i.e.cardiac/ renal/ hepatic/endocrine disorders. K/C/O Immune compromised patients or subjects of Immune suppressive drug. Helminthic infestation(H/o presence of helminithic in stool routine examination) Pregnancy and Lactation. Acute life threatening condition.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the changes in haemoglobin level by Mandurvatak alone or in combination with panchtiktghrit matra basti in comparison with Ferrous Sulphate.Timepoint: Assessment on 0th 30th 60th 90th days. | — |
Secondary
| Measure | Time frame |
|---|---|
| To monitor and compare the gastrointestinal side effects of all three groups.Timepoint: Assessment on 0th 30th 60th 90th days. | — |
Countries
India
Contacts
Dr. G. D.Pol Foundation, YMT Ayurvedic Medical College.